Skip to main content
Skip to main content

Assay for Screening HCV Drugs

Share:
Tech ID:
06-028
Principal Investigator:
Hengli Tang
Licensing Manager:
Patents:
Description:

More than 170 million people worldwide are infected with the Hepatitis C Virus (HCV), which can lead to acute and chronic liver diseases. Since the virus will not reproduce in test tubes for more than a few hours it is very difficult to perform experimental research on it. This novel assay uses a reporter cell line, causing the cells to send out a detectable signal when certain events happen internally. Whenever HCV is replicating, the cell will emit green fluorescence. The fluorescence is then tracked in the cell culture through flow cytometry.

Download PDF Version

Applications:

  • HCV testing
  • Rapidly identify and isolate antiviral drug candidates

Advantages:

  • Easy to use
  • Identifies HCV quickly relative to other assays